Outpatient Randomized Controlled Trials in the Covid-19 Era and Beyond.
NEJM Evid
; 1(12): EVIDctcs2200149, 2022 Dec.
Article
en En
| MEDLINE
| ID: mdl-38319835
ABSTRACT
Outpatient Trials in the Covid-19 Era and BeyondA group of investigators had a meeting at the National Heart, Lung, and Blood Institute in May 2020 to discuss ways to decrease thrombotic complications among symptomatic outpatients with Covid-19. The investigators discuss their approach to three specific challenges conducting a trial remotely, working through regulatory hurdles, and recruiting a diverse population of participants.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
COVID-19
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
En
Revista:
NEJM Evid
Año:
2022
Tipo del documento:
Article